The present invention is directed to assays that can be used to screen for compounds that act as agonists or antagonists or inverse agonists of bovine adrenal medulla docosapeptide (BAM-22P). The assays are based upon the binding of BAM-22P to the rat and human DRR receptors.

 
Web www.patentalert.com

> 3,4-disubstituted benzamidines and benzylamines, and analogues thereof, useful as serine protease inhibitors

~ 00377